ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.4753
-0.0096 (-1.98%)
May 16, 2025, 9:57 AM - Market open
ImmunoPrecise Antibodies Stock Forecast
IPA's stock price has decreased by -59.59% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for ImmunoPrecise Antibodies stock ranges from a low of $3.00 to a high of $5.00. The average analyst price target of $4.00 forecasts a 741.57% increase in the stock price over the next year.
Price Target: $4.00 (+741.57%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 11, 2025.
Analyst Ratings
The average analyst rating for ImmunoPrecise Antibodies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +951.97% | Apr 11, 2025 |
| Benchmark | Benchmark | Buy Reiterates $3 | Buy | Reiterates | $3 | +531.18% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $5 | Strong Buy | Maintains | $7 → $5 | +951.97% | Mar 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,372.75% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +1,372.75% | Dec 11, 2024 |
Financial Forecast
Revenue This Year
25.66M
from 24.52M
Increased by 4.67%
Revenue Next Year
29.30M
from 25.66M
Increased by 14.15%
EPS This Year
-0.64
from -1.06
EPS Next Year
-0.11
from -0.64
Financial currency is CAD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 27.4M | 30.5M | 40.2M | |||
| Avg | 25.7M | 29.3M | 38.7M | |||
| Low | 24.2M | 28.4M | 37.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 11.9% | 18.7% | 37.3% | |||
| Avg | 4.7% | 14.1% | 32.1% | |||
| Low | -1.3% | 10.8% | 28.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.26 | -0.12 | 0.02 |
| Avg | -0.64 | -0.11 | 0.02 |
| Low | -0.99 | -0.11 | 0.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.